Walleye Trading
CAPR icon

Walleye Trading’s Capricor Therapeutics CAPR Stock Holding History

Walleye Trading’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-20
Closed -$1K – 4728
2016
Q3 		$1K Buy
+20
New +$752 ﹤0.01% 4690
2016
Q1 		– Sell
-330
Closed -$10K – 5342
2015
Q4 		$10K Buy
330
+310
+1,550% +$12.3K ﹤0.01% 4720
2015
Q3 		$1K Buy
+20
New +$891 ﹤0.01% 4818

Other funds holding CAPR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Walleye Trading's CAPR Position: Q4 2016 in Review

Walleye Trading sold out of Capricor Therapeutics (CAPR) in Q4 2016, closing a stake of 20 shares — an estimated $1K sold.

Walleye Trading first reported a position in CAPR in Q3 2015 and held it in 3 quarters. The position peaked at $10K in Q4 2015. 20 funds tracked by Wall St. Rank hold CAPR as of Q4 2016.

  • Walleye Trading reported no remaining Capricor Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Walleye Trading sold 20 Capricor Therapeutics shares in Q4 2016, an estimated $1K.
  • Walleye Trading first reported a position in Capricor Therapeutics in Q3 2015 and held it in 3 quarters.
  • Walleye Trading's Capricor Therapeutics position peaked at $10K in Q4 2015.
  • 20 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q4 2016.

Based on Walleye Trading's 13F filing for Q4 2016, filed 14 Feb 2017.